Hyper nuclear acetylation (HNA) in proliferation, differentiation and apoptosis

Ageing Research Reviews

Volumn 2, Issue 3, 2003, Pages 287-297

  Kawahara, Ko Ichi ^a,b   Kawabata, Hisashi ^a   Aratani, Satoko ^b   Nakajima, Toshihiro ^b  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

CREB binding protein (CBP); Histone acetyltransferase; Hyper nuclear acetylation (HNA); p300 CBP associated factor (P CAF)

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; ACYLTRANSFERASE; BINDING PROTEIN; CALCIUM; CYCLIC AMP; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYCLOHEXIMIDE; ENZYME INHIBITOR; G 06983; HISTONE; INVOLUCRIN; LYSINE; NUCLEAR PROTEIN; PROTEIN P53; QUINIDINE; THROMBIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; HISTONE ACETYLTRANSFERASE; SACCHAROMYCES CEREVISIAE PROTEIN;

ACETYLATION; APOPTOSIS; ATHEROSCLEROSIS; ATTENUATION; CANCER; CELL PROLIFERATION; DEACETYLATION; DIFFERENTIATION; ENZYME ACTIVITY; EUKARYOTE; HUMAN; KERATINOCYTE; NONHUMAN; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SYNOVIOCYTE; VASCULAR SMOOTH MUSCLE; ANIMAL; CELL DIFFERENTIATION; CELL DIVISION; CELL NUCLEUS; CYTOLOGY; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; RHEUMATOID ARTHRITIS; SMOOTH MUSCLE FIBER;

EUKARYOTA;

ACETYLATION; ACETYLTRANSFERASES; ANIMALS; APOPTOSIS; ARTHRITIS, RHEUMATOID; CELL DIFFERENTIATION; CELL DIVISION; CELL NUCLEUS; HISTONE ACETYLTRANSFERASES; HISTONES; HUMANS; MYOCYTES, SMOOTH MUSCLE; SACCHAROMYCES CEREVISIAE PROTEINS;

EID: 0642309886     PISSN: 15681637     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1568-1637(03)00014-X     Document Type: Review

References (39)

1. Asahara H., Fujisawa K., Kobata T., Hasunuma T., Maeda T., Asanuma M., Ogawa N., Inoue H., Sumida T., Nishioka K. Direct evidence of high DNA binding activity of transcription factor AP-1 in rheumatoid arthritis synovium. Arthritis Rheum. 40:1997;912-918.
2. Brownell J.E., Allis C.D. Special HATs for special occasions: linking histone acetylation to chromatin assembly and gene activation. Curr. Opin. Genet. Dev. 6:1996;176-184.
3. Cho H., Orphanides G., Sun X., Yang X.J., Ogryzko V., Lees E., Nakatani Y., Reinberg D. A human RNA polymerase II complex containing factors that modify chromatin structure. Mol. Cell. Biol. 87:1998;5355-5363.
4. Collins T. Endothelial nuclear factor-kappa B and the initiation of the atherosclerotic lesion. Lab. Invest. 68:1993;499-508.
5. Firestein G.S., Nguyen K., Aupperle K.R., Yeo M., Boyle D.L., Zvaifler N.J. Apoptosis in rheumatoid arthritis: p53 overexpression in rheumatoid arthritis synovium. Am. J. Pathol. 149:1996;2143-2151.
6. Fujisawa K., Aono H., Hasunuma T., Mita S., Nishioka K. Activation of transcription factor NF-kappa B in human synovial cells in response to tumor necrosis factor alpha. Arthritis Rheum. 39:1996;197-203.
7. Giordano A., Avantaggiati M.L. p300 and CBP: partners for life and death. J. Cell Physiol. 181:1999;218-230.
8. Goodman R.H., Smolik S. CBP/300 in cell growth, transcription and development. Genes Dev. 14:2000;1553-1577.
9. Grunstein M. Histone acetylation in chromatin structure and transcription. Nature. 389:1997;349-352.
10. Gu W., Roeder R.G. Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell. 90:1997;595-606.
11. Hebbs T.R., Thorne A.W., Crane-Robinson C. A direct link between core histone acetylation and transcriptionally active chromatin. EMBO J. 7:1988;1395-1402.
12. Imhof A., Yang X., Ogryzko V.V., Nakatani Y., Wolffe A.P., Ge H. Acetylation of general transcription factors by histone acetyltransferase. Curr. Biol. 7:1997;689-692.
13. Inazuka M., Tahira T., Horiuchi T., Harashima S., Sawabe T., Kondo M., Miyahara H., Hayashi K. Analysis of p53 tumor suppressor gene somatic mutations in rheumatoid arthritis synovium. Rheumatology. 39:2000;262-266.
14. Janknecht R., Hunter T. Transcription control: versatile molecular glue. Curr. Biol. 6:1996;22-23.
15. Kawabata H., Kawahara K., Kanekura K., Araya N., Daitoku H., Hatta M., Miura N., Fukamizu A., Kanzaki T., Maruyama I., Nakajima T. Possible role of transcriptional coactivator P/CAF and nuclear acetylation in calcium-induced keratinocyte. J. Biol. Chem. 277:2002;8099-8105.
16. Kawahara K., Watanabe S., Ohshima T., Soejima Y., Oishi T., Aratani S., Nakata M., Shibata M., Inoue K., Amano T., Fujii R., Yanai K., Hagiwara M., Fukamizu A., Maruyama I., Nakajima T. Hypernuclear acetylation in atherosclerotic lesions and activated vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 266:1999;417-424.
17. Khoa N.D., Nakazawa M., Hasunuma T., Nakajima T., Nakamura H., Kobata T., Nishioka K. Potential role of HOXD9 in synoviocyte proliferation. Arthritis Rheum. 44:2001;1013-1021.
18. Kitasato H., Okamoto R., Kawai S. Absence of p53 mutation in Japanese patients with rheumatoid arthritis: comment on the article by Han et al. Arthritis Rheum. 43:2000;469-470.
19. Korzu E., Torchia J., Rose D.W., Xu L., Kurokawa R., McInerney E.M., Mullen T.-M., Glass C.K., Rosenfeld M.G. Transcription factor-specific recruitment of co-activators and their acetyltransferase functions. Science. 279:1998;703-707.
20. Kullmann F., Judex M., Neudecker I., Lechner S., Justen H.P., Green D.R., Wessinghage D., Firestein G.S., Gay S., Scholmerich J., Muller-Ladner U. Analysis of p53 tumor suppressor gene in rheumatoid arthritis synovial fibroblast. Arthritis Rheum. 42:1999;1594-1600.
21. Lafyatis R., Remmers E.F., Robert A.B., Yocum D.E., Sporn M.B., Wilder R.L. Anchorage-independent growth of synoviocytes from arthritic and normal joints. Stimulation by exogenous platelet-derived growth factor and inhibition by transforming growth factor-beta and retinoids. J. Clin. Invest. 83:1989;1267-1276.
22. Lee D.Y., Hayes J.J., Pruss D., Wolffe A.P. A positive role for histone acetylation in transcription factor access to nucleosomal DNA. Cell. 72:1993;72-84.
23. Lill N.L., Grossman S.R., Ginsberg D., DeCaprio J., Livingstone D.M. Binding and modulation of p53 by p300/CBP co-activators. Nature. 387:1997;823-827.
24. Marks P.A., Richon V.M., Rifkind R.A. Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells. J. Natl. Cancer. Inst. 92:2000;1210-1216.
25. Maruyama I., Shigeta K., Miyahara H., Nakajima T., Shin H., Ide S., Kitajima I. Thrombin activates NF-kappa B through thrombin receptor and results in proliferation of vascular smooth muscle cells: role of thrombin in atherosclerosis and restenosis. Ann. N. Y. Acad. Sci. 811:1997;429-466.
26. Mizzen C.A., Allis C.D. Linking histone acetylation to transcriptional regulation. Cell. Mol. Life. Sci. 54:1998;6-20.
27. Montminy M. Transcriptional activation. Something new to hang your HAT on. Nature. 387:1997;654-655.
28. Nakajima T., Uchida C., Anderson S.F., Lee C.G., Hurwitz J., Parvin J.D., Montminy M. RNA helicase A mediates association of CBP with RNA polymerase II. Cell. 90:1997a;1107-1112.
29. Nakajima T., Uchida C., Anderson S.F., Parvin J.D., Montminy M. Analysis of a cAMP-responsive activator reveals a two-component mechanism for transcriptional induction via signal-dependent factors. Genes Dev. 11:1997b;738-747.
30. Nakazawa M., Aratani S., Hatta M., Araya N., Daitoku H., Kawahara K., Watanabe S., Nakamura H., Yoshino S., Fujii R., Fujita H., Fukamizu A., Nishioka K., Nakajima T. TNFα induces acetylation of p53 but attenuated its transcriptional activation in rheumatoid arthritis. Int. J. Mol. Med. 10:2002;269-275.
31. Ogryzko V.V., Schlitz R.L., Russanova V., Howard B.H., Nakatani Y. The transcriptional co-activators p300 and CBP are histone acetyltransferases. Cell. 87:1996;953-959.
32. Shikama N., Lyon J., La Thangue N.B. The CBP family: integrating signals with transcription factors and chromatin. Trends Cell Biol. 7:1997;230-236.
33. Struhl K. Histone acetylation and transcriptional regulatory mechanisms. Genes Dev. 12:1998;599-606.
34. Suzuki T., Nagai R., Yazaki Y. Mechanisms of transcriptional regulation of gene expression in smooth muscle cells. Circ. Res. 82:1998;1238-1242.
35. Vogelstein B., Lane D., Levine A.J. Surfing the p53 network. Nature. 408:1998;307-310.
36. Waltzer L., Bienz M. Drosophila CBP represses the transcription factor TCF to antagonize wingless signalling. Nature. 395:1998;521-525.
37. Wolffe A.P., Pruss D. Targeting chromatin disruption: transcription regulators that acetylate histones. Cell. 84:1996;817-819.
38. Yuan L.W., Gambee J.E. Phosphorylation of p300 at serine 89 by protein kinase. C.J. Biol. Chem. 275:2000;40946-40951.
39. Zhou Q., Melkoumian Z.K., Lucktong A., Moniwa M., Davie J.R., Strobl J.S. Rapid induction of histone hyperacetylation and cellular differentiation in human breast tumor cell lines following degradation of histone deacetylase-1. J. Biol. Chem. 275:2000;35256-35263.